Catalyst Wire Dossier Catalyst Wire Dossier

TAZORAC® (Tazarotene) Cream 0.05%

tazarotene · Sun Pharmaceutical/Fougera
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAZORAC® (Tazarotene) Cream 0.05%, covering 2018-08-29 to 2018-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis [Phase 3]

See pricing